Header cover image

Egyptian (OMX) Pharma Industry Analysis

UpdatedMay 30, 2024
DataAggregated Company Financials
Companies11
  • 7D2.4%
  • 3M-18.5%
  • 1Y27.3%
  • YTDn/a

In the last week, the Pharma industry is up 2.4%, with all of the companies up. This means that the industry has gained 27% over the past year. As for the next few years, earnings are expected to grow by 20% per annum.

Industry Valuation and Performance

Has the Egyptian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 31 May 2024ج.م19.1bج.م20.1bج.م1.8b7.8x10.4x0.9x
Sun, 28 Apr 2024ج.م20.0bج.م19.8bج.م1.9b7.8x10.7x1x
Tue, 26 Mar 2024ج.م22.3bج.م19.4bج.م2.3b8.7x9.9x1.2x
Thu, 22 Feb 2024ج.م24.3bج.م18.5bج.م2.4b10.2x10.2x1.3x
Sat, 20 Jan 2024ج.م19.5bج.م16.4bج.م2.2b7.4x8.9x1.2x
Mon, 18 Dec 2023ج.م19.1bج.م16.5bج.م2.2b8.7x8.8x1.2x
Wed, 15 Nov 2023ج.م15.2bج.م15.4bج.م1.9b7.9x7.8x1x
Fri, 13 Oct 2023ج.م14.2bج.م15.4bج.م1.9b5.3x7.3x0.9x
Sun, 10 Sep 2023ج.م14.4bج.م15.9bج.م2.0b7.2x7.1x0.9x
Tue, 08 Aug 2023ج.م13.5bج.م15.7bج.م2.1b7.5x6.5x0.9x
Thu, 06 Jul 2023ج.م13.9bج.م15.6bج.م2.1b7.2x6.6x0.9x
Sat, 03 Jun 2023ج.م13.8bج.م16.1bج.م2.2b5.4x6.2x0.9x
Mon, 01 May 2023ج.م14.2bج.م16.2bج.م2.4b5.2x5.9x0.9x
Wed, 29 Mar 2023ج.م13.9bج.م15.7bج.م2.3b5.2x6.1x0.9x
Fri, 24 Feb 2023ج.م14.3bج.م15.7bج.م2.3b5.4x6.2x0.9x
Sun, 22 Jan 2023ج.م15.1bج.م15.6bج.م2.3b5.3x6.6x1x
Tue, 20 Dec 2022ج.م14.7bج.م15.6bج.م2.3b5.3x6.5x0.9x
Thu, 17 Nov 2022ج.م13.5bج.م15.1bج.م2.2b5.1x6.3x0.9x
Sat, 15 Oct 2022ج.م12.5bج.م15.1bج.م2.2b4.7x5.8x0.8x
Mon, 12 Sep 2022ج.م13.0bج.م14.3bج.م2.0b6.1x6.4x0.9x
Wed, 10 Aug 2022ج.م12.5bج.م14.1bج.م1.9b5.7x6.5x0.9x
Fri, 08 Jul 2022ج.م11.8bج.م14.1bج.م1.9b5.6x6.1x0.8x
Sun, 05 Jun 2022ج.م11.9bج.م12.1bج.م1.7b5.6x7x1x
Tue, 03 May 2022ج.م12.3bج.م11.9bج.م1.7b5.7x7.4x1x
Thu, 31 Mar 2022ج.م12.7bج.م13.7bج.م1.8b6.5x6.9x0.9x
Sat, 26 Feb 2022ج.م12.7bج.م13.4bج.م1.8b6.3x6.9x0.9x
Mon, 24 Jan 2022ج.م13.7bج.م13.3bج.م1.8b6.3x7.5x1x
Wed, 22 Dec 2021ج.م13.6bج.م13.3bج.م1.8b6.7x7.5x1x
Fri, 19 Nov 2021ج.م11.8bج.م13.1bج.م1.8b5.9x6.7x0.9x
Sun, 17 Oct 2021ج.م12.5bج.م12.9bج.م1.8b5.5x7.1x1x
Tue, 14 Sep 2021ج.م13.6bج.م13.0bج.م1.8b5x7.6x1x
Thu, 12 Aug 2021ج.م13.5bج.م13.0bج.م1.8b5x7.6x1x
Mon, 07 Jun 2021ج.م12.3bج.م12.6bج.م1.7b5.3x7.4x1x
Price to Earnings Ratio

7.4x


Total Market Cap: ج.م12.3bTotal Earnings: ج.م1.7bTotal Revenue: ج.م12.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Egyptian Pharma Industry Price to Earnings3Y Average 7.2x202220232024
Current Industry PE
  • Investors are optimistic on the Egyptian Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 10.4x which is higher than its 3-year average PE of 7.2x.
  • The industry is trading close to its 3-year average PS ratio of 0.97x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 3.1% per year over the last three years.
  • Revenues for these companies have grown 17% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Egyptian Pharma compare with similar industries?

EG Market-0.73%
Healthcare3.82%
Pharma2.39%
Pharma2.39%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
MIPH MINAPHARM Pharmaceuticalsج.م213.506.6%
+ج.م146.5m
-3.0%PS0.6x
PHAR Egyptian International Pharmaceutical Industriesج.م38.402.6%
+ج.م145.8m
47.1%PE6.9x
RMDA Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)Eج.م2.244.2%
+ج.م134.1m
46.4%PE15.6x
MPCI Memphis Pharmaceuticals & Chemical Industriesج.م84.100.4%
+ج.م2.1m
204.4%PE2.1x
BIOC GlaxoSmithKlineEج.م28.990.03%
+ج.م835.1k
-12.9%PE64.3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.